期刊文献+

Raf-1对人血管内皮细胞增殖及细胞周期的影响 被引量:2

The function of raf-1 in proliferation,cell cycle of human vascular endothelial cells
下载PDF
导出
摘要 目的:探讨Raf-1蛋白激酶在血管内皮细胞生长增殖中的作用。方法:分别应用Raf-1蛋白激酶的真核表达载体pCDNA3-raf-1及干涉核苷酸片段Raf-1-siRNA转染人脐静脉内皮细胞(HUVECs),进而应用MTT法绘制HUVECs生长曲线,应用流式细胞仪分析细胞周期。结果:HUVECs转染真核表达载体后,细胞内Raf-1明显增高,与对照组比较,细胞增殖速度明显加快;而转染Raf-1-siRNA后,HUVECs细胞中Raf-1表达水平降低,与对照组比较,细胞增殖速度明显减慢,阻滞于G_1期。结论:Raf-1蛋白激酶在血管内皮细胞生长增殖中发挥重要作用。 Objective:To investigate the function of Raf-1in cell proliferation and cell cycles in vascular endothelial cells.Methods:The Human Umbilical Vein Endothelial Cells(HUVECs)were transfected with the eukaryotic expression vector pCDNA3-raf-1or Small interference RNA Raf-1-siRNA.Then,the cells growth curves were draw according of MTT,and cell cycles were detected by FACs.Results:After the HUVECs were transfected with the eukaryotic expression vector pCDNA3-raf-1,the proliferation of HUVECs increased significantly than the control.Vice versa,after the HUVECs were transfected with Raf-1-siRNA,the Raf-1expression decreased,and the amplification of HUVECs was slower down than the control,the cell cycles were arrested at G1 phase.Conclusion:The raf-1plays an important role in the growth of vascular endothelial cells.
出处 《陕西医学杂志》 CAS 2016年第10期1283-1284,1350,共3页 Shaanxi Medical Journal
关键词 丝裂原活化蛋白激酶磷酸酶 人脐静脉内皮细胞 肿瘤转移 @肿瘤血管生成 Mitogen-activated protein kinase kinases Human umbilical vein endothelial cells Neoplasm metastasis @Vascular endothelial cells
  • 相关文献

参考文献9

二级参考文献100

  • 1周爱萍,孙燕.多靶点抗肿瘤新药索拉非尼的研究进展[J].癌症进展,2006,4(6):529-533. 被引量:57
  • 2焦宇,陆涛.抗肿瘤药物Raf激酶抑制剂的研究进展[J].海峡药学,2007,19(8):1-5. 被引量:7
  • 3O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiognesis and tumor growth[J].Cell,1997,88(2):277-285
  • 4Shichiri M,Hirata Y.Antiangiogenesis signals by endostatin[J].FASEBJ,2001,15(6):1004-1053
  • 5Huang X,Wong MK,Zhao Q,et al.Soluble recombinant endostatin purified from Escherichina coli:antiangiogenic activity and antitumor effect[J].Cancer Res,2001,61(2):478-481
  • 6Gasparini G.The rationale and future potential of angiogenesis inhibitors in neoplasia[J].Drugs,1999,58(1):17
  • 7Dy GK,Adjei AA.Understanding,recognizing,and managing toxicities of targeted anticancer therapies[J].CA Cancer J Clin,2013,63(4):249-279.
  • 8Stratton MR,Campbell PJ,Futreal PA.The cancer genome[J].Nature,2009,458(7239):719-724.
  • 9Tse BW,Collins A,Oehler MK,et al.Antibody-based immunotherapy for ovarian cancer:Where are we at[J]? Ann Oncol,2014,25(2):322-331.
  • 10Gala K,Chandarlapaty S.Molecular pathways:HER3 targeted therapy[J].Clin Cancer Res,2014,20(6):1410-1416.

共引文献10

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部